Dok Hyun Yoon
University of Ulsan
322 Papers
862 Citations
Dok Hyun Yoon is an academic researcher from University of Ulsan. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 30, co-authored 247 publications.
Chat about Author
Papers
A unique pattern of extranodal involvement in Korean adults with sporadic Burkitt lymphoma: a single center experience
Sun-Joo Jang,Dok Hyun Yoon,Shin Kim,Shinkyo Yoon,Dal Yong Kim,Chan-Sik Park,Jooryung Huh,Sang-wook Lee,Dae Ho Lee,Jin-Sook Ryu,Cheolwon Suh +10 more
TL;DR: The stomach, genitourinary tract, and bones were the most commonly involved extranodal sites in Korean BL patients, but site had no prognostic significance.
Comprehensive analysis of peripheral T-cell and natural killer/T-cell lymphoma in Asian patients: A multinational, multicenter, prospective registry study in Asia.
Sang Eun Yoon,Yuqin Song,Seok Jin Kim,Dok Hyun Yoon,Tsai Yun Chen,Youngil Koh,Ka Won Kang,Ho Sup Lee,Kevin Tay,Soon Thye Lim,Michelle Poon,Cosphiadi Irawan,Wei-Li Zhao,Young Rok Do,Mark Hong Lee,Soo Chin Ng,Won Sik Lee,Ye Guo,Huilai Zhang,Hye Jin Kang,Hwan Jung Yun,Hyo Jung Kim,Daryl Tan Chen Lung,Jae Yong Kwak,Jae Joon Han,Yeung-Chul Mun,Sung Yong Oh,Hyeok Shim,Jung Hye Kwon,Byeong Seok Sohn,Seong Kyu Park,Jae Cheol Jo,Young Hyeh Ko,Zhu Jun,Won Seog Kim +34 more
- 22 Mar 2021
TL;DR: In patients with PTCLs other than ENKTL, anthracycline-containing chemotherapies were widely used, but the outcome of those regimens was not satisfactory, and upfront autologous SCT was not significantly associated with survival benefit, either.
Phase 1b/2a Study of AZD4573 (CDK9i) and Acalabrutinib in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma (r/r DLBCL): Results from Dose-Escalation
Paolo Strati,Tae Min Kim,Alexey V. Danilov,Chan Yoon Cheah,Dok Hyun Yoon,Wojciech Jurczak,Shri Niwas Sharma,Jeong L. Yoon,Serena Arduini,Jamal Carlos Saeh,Richard F. Olsson,Gareth P. Gregory +11 more
TL;DR: Azd4573, a potent and highly selective inhibitor of CDK9, triggers downregulation of MCL-1, BFL-1 and MYC, rapidly inducing apoptosis in human hematological cancer cell lines as discussed by the authors .
Cardiovascular Toxicity after Carfilzomib, Lenalidomide, and Dexamethasone Combination Chemotherapy in the Real-World 364 Asian Multiple Myeloma Patients on Behalf of the Korean Multiple Myeloma Working Party (KMM2201 study)
Ji Hyun Lee,C. Min,Jae-Cheol Jo,Yoo Jin Lee,Jin Seok Kim,Hyun-Seok Uhm,J. Jung,Joon Ho Moon,Hee Jeong Cho,Myung-won Lee,Sung-Soo Yoon,Ja Min Byun,Jae Hoon Lee,Je-Jung Lee,S. Jung,Ho-Jin Shin,Do Young Kim,Jun Ho Yi,Seung-Shin Lee,Young Rok Do,Dok Hyun Yoon,Hyung-Ho Cho,Won-Sik Lee,Ho Sup Lee,Jieun Uhm,Hyo Jung Kim,Hee-Ryeong Jang,Sung-Hyun Kim,Kihyun Kim +28 more
TL;DR: The incidence of CVAE after KRd therapy in this large cohort of real-world Asian RRMM patients was comparable with previous prospective and retrospective studies, which necessitates cautious risk management for patients who are treated with carfilzomib-based combination regimen.
Current Treatment Patterns and the Role of Upfront Autologous Stem Cell Transplantation in Patients with Peripheral T-Cell Lymphoma: A Korean Nationwide, Multicenter Prospective Registry Study (CISL 1404)
Hyung-Ho Cho,Dok Hyun Yoon,Dong Yeop Shin,Youngil Koh,Sung-Soo Yoon,Seok Jin Kim,Young Rok Do,Gyeong Won Lee,Jae-Yong Kwak,Yong Lae Park,Min Kyoung Kim,Hye Jin Kang,Jun Ho Yi,K.H. Yoo,Won Sik Lee,Byeong-Bae Park,Jae-Cheol Jo,Hyeon Seok Eom,Hyo Jung Kim,Seong Hyun Jeong,Young Woong Won,Byeong Seok Sohn,Ji Hyun Kwon,Cheolwon Suh,Won Seog Kim +24 more
TL;DR: In this article , the authors conducted a nationwide, multicenter, prospective registry study for newly diagnosed patients with peripheral T-cell lymphoma (PTCL) to better define the clinical characteristics, treatment patterns, survival outcomes, and the role of upfront autologous stem cell transplantation (ASCT) in these patients.